Temporarily mouth, throat or nose, digestive tract and to eliminate the pain. Determined by your doctor as it can also be used for other conditions. Nerve transmission of pain impulses from the brain by preventing functions.

Certificate of Analysis

• Description

  White or almost white crystalline powder.

  Result

  Almost white crystalline powder.

• Solubility

  Practically insoluble in water, very soluble in ethanol & in methylene chloride.

  Result

  Complies

• Identification

  To comply IR Test.

  Result

  Complies

• Related Substance

  Result

  Complies

• Impurity A

  NMT 0.01%

  Result

  Not detected

• Unspecified Impurities

  NMT 0.10%

  Result

  0.0569%

• Total Impurities

  NMT 0.5%

  Result

  0.0946%

• Chloride

  NMT 35 PPM

  Result

  Complies

• Sulphates

  NMT 0.1%

  Result

  Complies

• Water

  NMT 1.0% w/w

  Result

  0.47% w/w

• Sulphated Ash

  NMT 0.1% w/w

  Result

  0.070% w/w

• Assay

  NLT 99.0% & NMT 101% of C14H22N2O, on anhydrous basis.

  Result

  99.51% w/w

Note: Note: – We are leading channel partner of much API manufacturer, supplier & exporters and Pharmaceutical raw material in Colombo, Chili, Ecuador and Globally.

Material Safety Data Sheet

• Section 1 – Chemical Product

  Product Identifier

  Lidocaine Base

  MSDS Prepared By

  R&D Department

• Section 2 – Composition / Information Of Ingredients

  Product Name

  Lidocaine Base

  Synonym

  2-Diethulamino-N-(2,6-dimethylphenyl)acetamide Lignocaine Xylocaine

  Molecular Formula

  C14H22N2O

  Molecular Weight

  234.34 g/mol

  CAS Number

  137-58-6

• Section 3 – HAZARDOUS IDENTIFICATION

  Acute Toxicity Oral

  Category 4

  Single Word

  Warning

  Hazard Statement(s)

  H302

  Harmful if swallowed.

  Precautionary Statement

  None

  Supplemental Hazard

  None

  R-Phrase(s)

  R22

  Harmful if swallowed.

  S-Phrase(s)

  S22

  Do not breathe dust.

  S26

  In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.

  S36

  Wear suitable protective clothing.

  Other Hazards

  None

• Section 4 – FIRST AID

  General Information

  Consult a physician. Show this safety data sheet to the doctor in attendance.

  Eye Contact

  Flush eyes with water as a precaution.

  Skin Contact

  Wash off with plenty of water. Consult a physician.

  Inhalation

  If breathed in, move person into fresh air. If not breathing, give artificial respiration. Consult a physician.

  Ingestion

  Never give anything by mouth to an unconscious person. Rinse mouth with water. Consult a physician.

• Section 5 – FIRE FIGHTING MEASURES

  Suitable Extinguishing Media

  Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide.

  Special hazard arising from the Substance or Mixture

  Carbon oxides, Nitrogen Oxides (NOx)

  Advice for Fire-fighters

  Wear self-contaminated breathing apparatus for fire-fighting if necessary.

  Further Information

  N/A

• Section 6 – ACCIDENT RELEASE MEASURES

  Personal Precaution

  Use personal protective equipment. Avoid dust formation. Avoid breathing vapors, mist or gas. Ensure adequate ventilation. Avoid breathing dust.

  Environmental Precautions

  Do not allow to enter drains.

  Methods for Cleaning Up

  Pick up and arrange disposal without creating dust. Sweep up and shovel. Keep in suitable, closed containers for disposal.

• Section 7 – HANDLING AND STORAGE

  Handling

  Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Provide appropriate exhaust ventilation at places where dust is formed. Normal measures for preventive fire protection.

  Storage

  Store in cool place. Keep container tightly closed in a dry and well-ventilated place.

• Section 8 – EXPOSURE CONTROLS / PERSONAL PROTECTION

  Engineering Controls

  Handle in accordance with good industrial hygiene and safety practice. Wash hands before breaks and at the end of workday.

  Personal Protective Equipment

  Eye / Face Protection

  Safety glasses with side-shields conforming to EN166 Use equipment for eye protection tested and approved under appropriate government standards such as NIOSH (US) or EN 166(EU).

  Skin Protection

  Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique (without touching glove’s outer surface) to avoid skin contact with this product. Dispose of contaminated gloves after use in accordance with applicable laws and good laboratory practices. Wash and dry hands.

  Body Protection

  Complete suit protecting against chemicals, the type of protective equipment must be selected according to the concentration and amount of the dangerous substance at the specific workplace.

  Respiratory Protection

  For nuisance exposures use type P95 (US) or type P1 (EU EN 143) particle respirator. For higher level protection use type OV/AG/P99 (US) or type ABEK -P2 (EU EN 143) respirator cartridges. Use respirators and components tested and approved under appropriate government standards such as NIOSH (US) or CEN (EU).

• Section 9 – PHYSICAL AND CHEMICAL PROPERITIES

  Form

  Solid

  Odour

  N/A

  Odour Threshold

  N/A

  pH

  N/A

  Melting Point / Freezing Point

  Melting Point range 66 – 69° C

  Initial Boiling Point

  N/A

  Flash Point

  N/A

  Evaporation Rate

  N/A

  Flammability

  N/A

  Upper / Lower Flammability

  N/A

  Vapor Pressure

  N/A

  Vapor Density

  N/A

  Relative Density

  N/A

  Water Solubility

  N/A

  Partition Coeff.

  N/A

  Auto-Ignition Temperature

  N/A

  Decomposition Temperature

  N/A

  Viscosity

  N/A

  Explosive Properties

  N/A

  Oxidizing Properties

  N/A

• Section 10 – STABILITY AND REACTIVITY

  Reactivity

  N/A

  Chemical Stability

  N/A

  Possibility of Hazardous Reactions

  N/A

  Condition to Avoid

  N/A

  Incompatible Materials

  Strong oxidizing agents

  Hazardous Decomposition Product(s)

  N/A

• Section 11 – TOXICOLOGICAL INFORMATION

  Acute Toxicity

  LD50 Oral [Rat]

  317 mg/kg.

  Skin Corrosion / Irritation

  N/A

  Serious Eye Damage / Eye Irritation

  N/A

  Respiratory or Skin Sensitization

  N/A

  Germ Cell Mutagenicity

  N/A

  Carcinogenicity

  IARC

  No component of this product present at levels greater than or equal to 0.1% is identified as probable, possible or confirmed human carcinogen by IARC

  Specific Target Organ toxicity – Single Exposure

  N/A

  Specific Target Organ toxicity – Repeated Exposure

  N/A

  Aspiration Hazard

  N/A

  Potential Health Effects

  Eyes

  May cause eye irritation.

  Skin

  May be harmful of absorbed through skin. May cause skin irritation.

  Inhalation

  May be harmful if inhaled. May cause respiratory tract irritation.

  Ingestion

  Harmful if swallowed.

• Section 12 – ECOLOGICAL INFORMATION

  Toxicity

  N/A

  Persistence & Degradability

  N/A

  Bio Cumulative Potential

  N/A

  Mobility in Soil

  N/A

  Result of PBT & vPvB assessment

  N/A

  Other adverse Effects

  N/A

• Section 13 – DISPOSAL CONSIDERATION

  Product

  Offer surplus and non-recyclable solutions to a licensed disposal company. Contact a licensed professional waste disposal service to dispose of this material. Dissolve or mix the material with a combustible solvent and burn in a chemical incinerator equipped with an afterburner and scrubber.

  Contaminated Packaging

  Dispose of as unused product.

• Section 14 – TRANSPORT INFORMATION

  UN Number

  ADR/RID

  N/A

  IMDG

  N/A

  IATA

  N/A

  UN Proper Shipping Name

  ADR/RID

  Not dangerous good.

  IMDG

  Not dangerous good.

  IATA

  Not dangerous good.

  Transport Hazard Class(s)

  ADR/RID

  N/A

  IMDG

  N/A

  IATA

  N/A

  Packaging Group

  ADR/RID

  N/A

  IMDG

  N/A

  IATA

  N/A

  Environmental Hazards

  ADR/RID

  N/A

  IMDG Marine Pollutant

  N/A

  IATA

  N/A

• Section 15 – REGULATORY INFORMATION

  No data available.

• Section 16 – OTHER INFORMATION

  Global Pharma provides information contained herein in good faith but makes no representation as to its comprehensives or accuracy. This document is intended only as a guide to the appropriate precautionary handling of the material by a properly trained person using this product.

  Individuals receiving the information must exercise their independent judgment in determining its appropriateness for a particular purpose.

  GLOBAL PHARMA MAKES NO REPRESENTATIONS OR WARRANTIES, EITHER EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION ANY WARRANTIES OR MERCHANTABILITY, FITNESS FOR A PARTICULER PURPOSE WITH RESPECT TO THE INFORMATION SET FORTH HEREIN OR THE PRODUCT WHICH THE INFORMATION REEFERS. GLOBAL PHARMA WILL NOT BE RESPONSIBLE FOR DAMAGES RESULTING FROM USE OF RELIANCE UPON THIS INFORMATION.